Charles J. Eyermann

机构：Regeneron (United States)

发表论文 86 篇 · 总被引 4296 次 · h-index 31

代表论文

• SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (2021 · Cell stem cell · 被引 269)
• Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023 · Science · 被引 181)
• Plasmodial Kinase Inhibitors: License to Cure? (2018 · Journal of Medicinal Chemistry · 被引 67)
• Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping (2016 · ACS Infectious Diseases · 被引 61)
• Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target (2015 · Tuberculosis · 被引 50)
• Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria (2018 · Journal of Medicinal Chemistry · 被引 47)